Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELINOSTAT for Chondrosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where BELINOSTAT was used for Chondrosarcoma.

Most Reported Side Effects for BELINOSTAT

Side Effect Reports % Deaths Hosp.
Disease progression 64 21.0% 38 19
Nausea 50 16.4% 8 21
Death 40 13.1% 40 13
Vomiting 36 11.8% 6 18
Dyspnoea 31 10.2% 11 22
Anaemia 29 9.5% 6 13
Fatigue 27 8.9% 5 8
Constipation 24 7.9% 6 12
Platelet count decreased 24 7.9% 3 10
White blood cell count decreased 21 6.9% 1 7
Neutrophil count decreased 19 6.2% 3 8
Diarrhoea 18 5.9% 6 10
Pain 17 5.6% 6 8
Headache 16 5.3% 4 10
Pneumonia 16 5.3% 7 12

Other Indications for BELINOSTAT

Product used for unknown indication (75) Peripheral t-cell lymphoma unspecified (45) Acute myeloid leukaemia (16) Angioimmunoblastic t-cell lymphoma (16) Non-hodgkin's lymphoma (16) T-cell lymphoma (16) Peripheral t-cell lymphoma unspecified stage iv (12) Cutaneous t-cell lymphoma (8) Ovarian cancer (6) Ovarian cancer metastatic (5)

Other Drugs Used for Chondrosarcoma

CABOZANTINIB S-MALATE (146) DOXORUBICIN (42) PAZOPANIB (32) IFOSFAMIDE (28) CISPLATIN (22) VISMODEGIB (19) NIVOLUMAB (17) IVOSIDENIB (12) CYCLOPHOSPHAMIDE (11) METHOTREXATE (10)

Related Pages

BELINOSTAT Full Profile All Chondrosarcoma Drugs BELINOSTAT Demographics BELINOSTAT Timeline